BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schneider SA, Klein C. What is the role of genetic testing in movement disorders practice? Curr Neurol Neurosci Rep 2011;11:351-61. [PMID: 21465148 DOI: 10.1007/s11910-011-0200-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Surampalli A, Khare M, Kubrussi G, Wencel M, Tanaja J, Donkervoort S, Osann K, Simon M, Wallace D, Smith C, M McInerney-Leo A, Kimonis V. Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia. J Genet Couns 2015;24:842-50. [PMID: 25716352 DOI: 10.1007/s10897-015-9819-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
2 Ngueng Feze I, Salman S, Joly Y. Implications for Health and Life Insurances and Other Legal Aspects of Genetic Testing. Movement Disorder Genetics 2015. [DOI: 10.1007/978-3-319-17223-1_23] [Reference Citation Analysis]
3 Schneider SA. Clinical Phenomenology and Genetics of Other Parkinsonian Syndromes Associated with Either Dystonia or Spasticity. Movement Disorders 2015. [DOI: 10.1016/b978-0-12-405195-9.00057-3] [Reference Citation Analysis]
4 Borry P, Chokoshvili D, Niemiec E, Kalokairinou L, Vears DF, Howard HC. Current Ethical Issues Related to the Implementation of Whole-Exome and Whole-Genome Sequencing. Movement Disorder Genetics 2015. [DOI: 10.1007/978-3-319-17223-1_22] [Reference Citation Analysis]